BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

504 related articles for article (PubMed ID: 19190807)

  • 1. Shiga toxins, glycosphingolipid diversity, and endothelial cell injury.
    Müthing J; Schweppe CH; Karch H; Friedrich AW
    Thromb Haemost; 2009 Feb; 101(2):252-64. PubMed ID: 19190807
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Application of combined high-performance thin-layer chromatography immunostaining and nanoelectrospray ionization quadrupole time-of-flight tandem mass spectrometry to the structural characterization of high- and low-affinity binding ligands of Shiga toxin 1.
    Meisen I; Friedrich AW; Karch H; Witting U; Peter-Katalinić J; Müthing J
    Rapid Commun Mass Spectrom; 2005; 19(24):3659-65. PubMed ID: 16285017
    [TBL] [Abstract][Full Text] [Related]  

  • 3. On the structural diversity of Shiga toxin glycosphingolipid receptors in lymphoid and myeloid cells determined by nanoelectrospray ionization tandem mass spectrometry.
    Hoffmann P; Hülsewig M; Duvar S; Ziehr H; Mormann M; Peter-Katalinić J; Friedrich AW; Karch H; Müthing J
    Rapid Commun Mass Spectrom; 2010 Aug; 24(15):2295-304. PubMed ID: 20623712
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Shiga Toxins: An Update on Host Factors and Biomedical Applications.
    Liu Y; Tian S; Thaker H; Dong M
    Toxins (Basel); 2021 Mar; 13(3):. PubMed ID: 33803852
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Shiga Toxin (Stx)-Binding Glycosphingolipids of Primary Human Renal Cortical Epithelial Cells (pHRCEpiCs) and Stx-Mediated Cytotoxicity.
    Detzner J; Krojnewski E; Pohlentz G; Steil D; Humpf HU; Mellmann A; Karch H; Müthing J
    Toxins (Basel); 2021 Feb; 13(2):. PubMed ID: 33673393
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Shiga toxins induce apoptosis in pulmonary epithelium-derived cells.
    Uchida H; Kiyokawa N; Taguchi T; Horie H; Fujimoto J; Takeda T
    J Infect Dis; 1999 Dec; 180(6):1902-11. PubMed ID: 10558947
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Shiga toxin glycosphingolipid receptors in microvascular and macrovascular endothelial cells: differential association with membrane lipid raft microdomains.
    Betz J; Bielaszewska M; Thies A; Humpf HU; Dreisewerd K; Karch H; Kim KS; Friedrich AW; Müthing J
    J Lipid Res; 2011 Apr; 52(4):618-34. PubMed ID: 21252262
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New aspects in the pathogenesis of enteropathic hemolytic uremic syndrome.
    Karch H; Friedrich AW; Gerber A; Zimmerhackl LB; Schmidt MA; Bielaszewska M
    Semin Thromb Hemost; 2006 Mar; 32(2):105-12. PubMed ID: 16575685
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thin-Layer Chromatography in Structure and Recognition Studies of Shiga Toxin Glycosphingolipid Receptors.
    Detzner J; Pohlentz G; Müthing J
    Methods Mol Biol; 2021; 2291():229-252. PubMed ID: 33704756
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Shiga toxin glycosphingolipid receptors and their lipid membrane ensemble in primary human blood-brain barrier endothelial cells.
    Legros N; Dusny S; Humpf HU; Pohlentz G; Karch H; Müthing J
    Glycobiology; 2017 Jan; 27(1):99-109. PubMed ID: 27558838
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Shiga toxin genotype rather than the amount of Shiga toxin or the cytotoxicity of Shiga toxin in vitro correlates with the appearance of the hemolytic uremic syndrome.
    Orth D; Grif K; Khan AB; Naim A; Dierich MP; Würzner R
    Diagn Microbiol Infect Dis; 2007 Nov; 59(3):235-42. PubMed ID: 17931818
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Uncommon membrane distribution of Shiga toxin glycosphingolipid receptors in toxin-sensitive human glomerular microvascular endothelial cells.
    Betz J; Bauwens A; Kunsmann L; Bielaszewska M; Mormann M; Humpf HU; Karch H; Friedrich AW; Müthing J
    Biol Chem; 2012 Mar; 393(3):133-47. PubMed ID: 22718629
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral therapeutic agents with highly clustered globotriose for treatment of Shiga toxigenic Escherichia coli infections.
    Watanabe M; Matsuoka K; Kita E; Igai K; Higashi N; Miyagawa A; Watanabe T; Yanoshita R; Samejima Y; Terunuma D; Natori Y; Nishikawa K
    J Infect Dis; 2004 Feb; 189(3):360-8. PubMed ID: 14745692
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Application of thin-layer chromatography/infrared matrix-assisted laser desorption/ionization orthogonal time-of-flight mass spectrometry to structural analysis of bacteria-binding glycosphingolipids selected by affinity detection.
    Müsken A; Souady J; Dreisewerd K; Zhang W; Distler U; Peter-Katalinić J; Miller-Podraza H; Karch H; Müthing J
    Rapid Commun Mass Spectrom; 2010 Apr; 24(7):1032-8. PubMed ID: 20213676
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alternative pathway activation of complement by Shiga toxin promotes exuberant C3a formation that triggers microvascular thrombosis.
    Morigi M; Galbusera M; Gastoldi S; Locatelli M; Buelli S; Pezzotta A; Pagani C; Noris M; Gobbi M; Stravalaci M; Rottoli D; Tedesco F; Remuzzi G; Zoja C
    J Immunol; 2011 Jul; 187(1):172-80. PubMed ID: 21642543
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular Biology of
    Menge C
    Toxins (Basel); 2020 May; 12(5):. PubMed ID: 32456125
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Shiga toxin-glycosphingolipid interaction: Status quo of research with focus on primary human brain and kidney endothelial cells.
    Legros N; Pohlentz G; Steil D; Müthing J
    Int J Med Microbiol; 2018 Dec; 308(8):1073-1084. PubMed ID: 30224239
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Localization of Shiga toxins of enterohaemorrhagic Escherichia coli in kidneys of paediatric and geriatric patients with fatal haemolytic uraemic syndrome.
    Chaisri U; Nagata M; Kurazono H; Horie H; Tongtawe P; Hayashi H; Watanabe T; Tapchaisri P; Chongsa-nguan M; Chaicumpa W
    Microb Pathog; 2001 Aug; 31(2):59-67. PubMed ID: 11453701
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protection against Shiga Toxins.
    Kavaliauskiene S; Dyve Lingelem AB; Skotland T; Sandvig K
    Toxins (Basel); 2017 Feb; 9(2):. PubMed ID: 28165371
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bacteriophage cell lysis of Shiga toxin-producing Escherichia coli for top-down proteomic identification of Shiga toxins 1 & 2 using matrix-assisted laser desorption/ionization tandem time-of-flight mass spectrometry.
    Fagerquist CK; Zaragoza WJ
    Rapid Commun Mass Spectrom; 2016 Mar; 30(6):671-80. PubMed ID: 26864518
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.